Exact Mass: 446.2242
Exact Mass Matches: 446.2242
Found 500 metabolites which its exact mass value is equals to given mass value 446.2242
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Glycinoeclepin A
Isolated from kidney bean roots. Glycinoeclepin A is found in many foods, some of which are green bean, common bean, pulses, and yellow wax bean. Glycinoeclepin A is found in common bean. Glycinoeclepin A is isolated from kidney bean roots.
6beta-hydroxybudesonide
6β-hydroxybudesonide is a metabolite of budesonide. Budesonide is a glucocorticoid steroid for the treatment of asthma and non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. In addition, it is used for Crohns disease. (Wikipedia)
Acetylstrophanthidin
Tert-Butyl (4-(3-((7-(hydroxyamino)-7-oxoheptyl)carbamoyl)isoxazol-5-yl)phenyl)carbamate
Corticosterone-21-hemisuccinate
Prednisolone butyrate
6beta-Hydroxydexbudesonide
6beta-Angeloyloxy-10alpha-hydroxy-10-desoxo-pyrrhopappolide
(Z)-2,6-dimethyl-7-(4-methyl-5-oxooxolan-2-yl)-3-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]hept-5-enoic acid
(1S,2S,4R,5S,7R,8R,9R,10S)-2,4-diangeloxy-9-hydroxyguai-11(13)-en-8,12-olide
2alpha-acetoxy-6alpha-p-methoxybenzoyl-10beta-hydroxy-jaeschkeanadiol
14alpha,15beta-diacetoxy-3alpha-(4-methylsenecioyloxy)-14beta,15alpha,epoxy-alpha-isocedrene|14alpha,15beta-diacetoxy-3alpha-<4-methylsenecioyloxy>-14beta,15alpha,epoxy-alpha-isocedrene
Tri-Ac-(3beta,16alpha)-3,16,18-Trihydroxyandrost-5-en-17-one
6beta-(beta-2-Methylbutyryloxy)-pyrrhopappolide|6beta--pyrrhopappolide
17,21-Di-Ac-11,17-21-Trihydroxypregn-4-ene-3,20-dione,
3beta,5-Dihydroxy-14,15beta-epoxy-16beta-acetoxy-5beta,14beta-card-20(22)-enolid
3-Angeloyl,7,8-bis-(2-methylbutanoyl) -9,10-Epoxy-P-mentha-1,3,5-triene-3,7,8-triol|7,9-Di-(2-methylbutyryloxy)-8,10-epoxythymol-angelate
linalyl-6-O-(3-hydroxy-3-methylglutaroyl)-beta-D-glucopyranoside
2alpha-hydroxy-6alpha-p-methoxybenzoyl-10beta-acetoxy-jaeschkeanadiol
8alpha-angeloyloxy-11alpha-senecioyloxy-6alphaH,7alphaH-guaian-3-en-12,6-olide
caseabalansin F|rel-(5R,6R,8S,9S,10R,18S,19R)-18,19-diacetoxy-18,19-epoxy-6-methoxycleroda-3,13(16),14-trien-2-one
1,21-Di-Ac-(1alpha,11beta)-1,11,21-Trihydroxypregn-4-ene-3,20-dione
2beta,8alpha-di-angeloyloxy-10beta-hydroxy-6alphaH,7alphaH-guaian-3-en-12,6-olide
12-hydroxy-3beta,7beta,18alpha-triacetoxy-8,11,13-abietatriene
6,7-Di-Ac,Me ester-(6alpha,7beta,14alphaH)-6,7-Dihydroxy-17-vouacapanoic acid
8beta-angeloyloxy-3beta-(2-methylbutyryloxy)-1beta,10alpha-epoxy-1,10H-constunolide
3beta-angeloyloxy-6beta-(3-methylbutanoyloxy)furanoeremophilan-14-oic acid|3beta-angeloyloxy-6beta-(3-methylbutyryloxy)-furanoeremophilan-15-oic acid
patrinoside-aglycone-11-O-2-deoxy-beta-D-glucopyranoside
methyl 12(R*),13(S*)-diacetoxy-18-keto-5(Z),8(Z),10(E),14(Z),16(E)-eicosapentaenoate
2-alpha-acetoxy-6-alpha-anisoyloxy-4beta-hydroxy-7alpha,9alpha-epoxy-trans-carotane|ferkuhinin
1alpha-Hydroxy-3beta-isovaleryloxy-6-O-tigloylsteiractinolid
(1S,5R,7R,10R)-secoatractylolactone 11-O-beta-D-glucopyranoside|(1S,5R,7R,10R)-Secoatractylolactone 11-O-??-D-glucopyranoside
6beta-(2-methylbutyryloxy)-10beta-hydroxy-3alpha,4alpha,15,16-bis-epoxy-8betaH-cleroda-13(16),14-diene-20,12-olide|6beta-<2-methylbutyryloxy>-10beta-hydroxy-3alpha,4alpha,15,16-bis-epoxy-8betaH-cleroda-13(16),14-diene-20,12-olide
CAY10603
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors
Pravastatin sodium
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM. Pravastatin sodium (CS-514 sodium) is an HMG-CoA reductase inhibitor against sterol synthesis with IC50 of 5.6 μM.
5-hydroxy-2,2,6,6-tetramethyl-4-[3-methyl-1-[2,4,6-trihydroxy-3-(2-methylpropanoyl)phenyl]butyl]cyclohex-4-ene-1,3-dione
C21H34O10_2H-Cyclohepta[b]furan-2-one, 4-acetyl-6-[1-(beta-D-glucopyranosyloxy)-1-methylethyl]octahydro-8a-(hydroxymethyl)-, (3aS,4R,6R,8aR)
C25H34O7_7-Formyl-4,6-dihydroxy-6-(hydroxymethyl)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[1-benzofuran-2,1-naphthalen]-7-yl acetate
C25H34O7_7-Formyl-4,7-dihydroxy-6-(hydroxymethyl)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[1-benzofuran-2,1-naphthalen]-6-yl acetate
C21H34O10_[(1S,5R)-6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl]methyl 6-O-alpha-L-arabinopyranosyl-beta-D-glucopyranoside
2-[[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)methoxy]oxane-3,4,5-triol
2-[[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)methoxy]oxane-3,4,5-triol_major
(Z)-2,6-dimethyl-7-(4-methyl-5-oxooxolan-2-yl)-3-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]hept-5-enoic acid_major
2-[[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)methoxy]oxane-3,4,5-triol_minor
2-[[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(6,6-dimethyl-4-bicyclo[3.1.1]hept-3-enyl)methoxy]oxane-3,4,5-triol_83.2\\%
Ala Asn Arg Ser
Ala Asn Ser Arg
Ala Pro Pro Tyr
Ala Pro Tyr Pro
Ala Arg Asn Ser
Ala Arg Ser Asn
Ala Ser Asn Arg
Ala Ser Arg Asn
Ala Tyr Pro Pro
Phe Pro Pro Ser
Phe Pro Ser Pro
Phe Ser Pro Pro
Gly Gly Lys Trp
Gly Gly Trp Lys
Gly Lys Gly Trp
Gly Lys Trp Gly
Gly Asn Arg Thr
Gly Asn Thr Arg
Gly Gln Arg Ser
Gly Gln Ser Arg
Gly Arg Asn Thr
Gly Arg Gln Ser
Gly Arg Ser Gln
Gly Arg Thr Asn
Gly Ser Gln Arg
Gly Ser Arg Gln
Gly Thr Asn Arg
Gly Thr Arg Asn
Gly Trp Gly Lys
Gly Trp Lys Gly
His Pro Pro Pro
Ile Met Pro Ser
Ile Met Ser Pro
Ile Pro Met Ser
Ile Pro Ser Met
Ile Ser Met Pro
Ile Ser Pro Met
Lys Gly Gly Trp
Lys Gly Trp Gly
Lys Trp Gly Gly
Leu Met Pro Ser
Leu Met Ser Pro
Leu Pro Met Ser
Leu Pro Ser Met
Leu Ser Met Pro
Leu Ser Pro Met
Met Ile Pro Ser
Met Ile Ser Pro
Met Leu Pro Ser
Met Leu Ser Pro
Met Pro Ile Ser
Met Pro Leu Ser
Met Pro Ser Ile
Met Pro Ser Leu
Met Pro Thr Val
Met Pro Val Thr
Met Ser Ile Pro
Met Ser Leu Pro
Met Ser Pro Ile
Met Ser Pro Leu
Met Thr Pro Val
Met Thr Val Pro
Met Val Pro Thr
Met Val Thr Pro
Asn Ala Arg Ser
Asn Ala Ser Arg
Asn Gly Arg Thr
Asn Gly Thr Arg
Asn Arg Ala Ser
Asn Arg Gly Thr
Asn Arg Ser Ala
Asn Arg Thr Gly
Asn Ser Ala Arg
Asn Ser Arg Ala
Asn Thr Gly Arg
Asn Thr Arg Gly
Pro Ala Pro Tyr
Pro Ala Tyr Pro
Pro Phe Pro Ser
Pro Phe Ser Pro
Pro His Pro Pro
Pro Ile Met Ser
Pro Ile Ser Met
Pro Leu Met Ser
Pro Leu Ser Met
Pro Met Ile Ser
Pro Met Leu Ser
Pro Met Ser Ile
Pro Met Ser Leu
Pro Met Thr Val
Pro Met Val Thr
Pro Pro Ala Tyr
Pro Pro Phe Ser
Pro Pro His Pro
Pro Pro Pro His
Pro Pro Ser Phe
Pro Pro Tyr Ala
Pro Ser Phe Pro
Pro Ser Ile Met
Pro Ser Leu Met
Pro Ser Met Ile
Pro Ser Met Leu
Pro Ser Pro Phe
Pro Thr Met Val
Pro Thr Val Met
Pro Val Met Thr
Pro Val Thr Met
Pro Tyr Ala Pro
Pro Tyr Pro Ala
Gln Gly Arg Ser
Gln Gly Ser Arg
Gln Arg Gly Ser
Gln Arg Ser Gly
Gln Ser Gly Arg
Gln Ser Arg Gly
Arg Ala Asn Ser
Arg Ala Ser Asn
Arg Gly Asn Thr
Arg Gly Gln Ser
Arg Gly Ser Gln
Arg Gly Thr Asn
Arg Asn Ala Ser
Arg Asn Gly Thr
Arg Asn Ser Ala
Arg Asn Thr Gly
Arg Gln Gly Ser
Arg Gln Ser Gly
Arg Ser Ala Asn
Arg Ser Gly Gln
Arg Ser Asn Ala
Arg Ser Gln Gly
Arg Thr Gly Asn
Arg Thr Asn Gly
Ser Ala Asn Arg
Ser Ala Arg Asn
Ser Phe Pro Pro
Ser Gly Gln Arg
Ser Gly Arg Gln
Ser Ile Met Pro
Ser Ile Pro Met
Ser Leu Met Pro
Ser Leu Pro Met
Ser Met Ile Pro
Ser Met Leu Pro
Ser Met Pro Ile
Ser Met Pro Leu
Ser Asn Ala Arg
Ser Asn Arg Ala
Ser Pro Phe Pro
Ser Pro Ile Met
Ser Pro Leu Met
Ser Pro Met Ile
Ser Pro Met Leu
Ser Pro Pro Phe
Ser Gln Gly Arg
Ser Gln Arg Gly
Ser Arg Ala Asn
Ser Arg Gly Gln
Ser Arg Asn Ala
Ser Arg Gln Gly
Thr Gly Asn Arg
Thr Gly Arg Asn
Thr Met Pro Val
Thr Met Val Pro
Thr Asn Gly Arg
Thr Asn Arg Gly
Thr Pro Met Val
Thr Pro Val Met
Thr Arg Gly Asn
Thr Arg Asn Gly
Thr Val Met Pro
Thr Val Pro Met
Val Met Pro Thr
Val Met Thr Pro
Val Pro Met Thr
Val Pro Thr Met
Val Thr Met Pro
Val Thr Pro Met
Trp Gly Gly Lys
Trp Gly Lys Gly
Trp Lys Gly Gly
Tyr Ala Pro Pro
Tyr Pro Ala Pro
Tyr Pro Pro Ala
ethyl-1-(2,4,6-trihydroxy-3-isobutyrylphenyl)butyl]-4-cyclohexene-1,3-dione
acetylstrophanthidin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins Strophanidin acetylated at the 3beta-hydroxy group.
4,8-Bis[(2-ethylhexyl)oxy]benzo[1,2-b:4,5-b]dithiophene
3-Cyclohexyl-1-(2-morpholin-4-YL-2-oxoethyl)-2-phenyl-1H-indole-6-carboxylic acid
2-Butoxy-9-(2,6-Difluorobenzyl)-N-(2-Morpholin-4-Ylethyl)-9h-Purin-6-Amine
N-[(13-Cyclohexyl-6,7-Dihydroindolo[1,2-D][1,4]benzoxazepin-10-Yl)carbonyl]-2-Methyl-L-Alanine
2-[3-Methyl-4-(N-methyl-guanidino)-butyrylamino]-3-(4-phenylethynyl-phenyl)-propionic acid methyl ester
(2S)-2-azaniumyl-5-[[(2R)-1-(carboxylatomethylamino)-3-decylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoate
[11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-1-yl] butanoate
2-[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]-1-(8-methyl-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)ethanone
N-[3-[4-(2,3-dimethylphenyl)-1-piperazinyl]-3-oxopropyl]-2-(1-oxo-2-isoquinolinyl)acetamide
methyl 6-O-alpha-L-arabinopyranosyl-6-C-[(1S,5R)-6,6-dimethylbicyclo[3.1.1]heptan-2-ylidene]-beta-L-idopyranoside
1,3-benzodioxol-5-yl-[(2R,3R)-1-(cyclopropylmethyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]methanone
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
[(3aR,4R,9bR)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
2-cyclopropyl-1-[(1S)-1-(hydroxymethyl)-7-methoxy-1-(3-pyridinylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
(6R,7R,8S)-8-(hydroxymethyl)-4-(oxane-4-carbonyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8R)-8-(hydroxymethyl)-4-(oxane-4-carbonyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7S,8S)-8-(hydroxymethyl)-4-(oxane-4-carbonyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3S,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3R,6R)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3S,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3R,6S)-6-[2-[4-[(dimethylamino)methyl]-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]urea
[(3aR,4R,9bS)-8-(1-cyclohexenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-(1,3-benzodioxol-5-yl)methanone
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(4-oxanyl)methanone
2-cyclopropyl-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
2-cyclopropyl-1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-(3-pyridinylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
1,3-benzodioxol-5-yl-[(2S,3S)-1-(cyclopropylmethyl)-2-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]methanone
(6S,7R,8R)-8-(hydroxymethyl)-4-(oxane-4-carbonyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6S,7S,8S)-8-(hydroxymethyl)-4-(oxane-4-carbonyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
(6R,7R,8R)-8-(hydroxymethyl)-4-(oxane-4-carbonyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
2-cyclopropyl-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
8-methoxy-3-[(E)-[4-methoxy-3-(pyrrolidin-1-ylmethyl)phenyl]methylideneamino]-2-methyl-5H-pyrimido[5,4-b]indol-1-ium-4-one
(3aalpha,4R)-4alpha-Acetyl-6alpha-[1-methyl-1-(beta-D-glucopyranosyloxy)ethyl]-8aalpha-(hydroxymethyl)octahydro-2H-cyclohepta[b]furan-2-one
2-[1-(2-Hydroxy-3,3,5,5-tetramethyl-4,6-dioxo-1-cyclohexenyl)-3-methylbutyl]-4-(2-methylpropanoyl)benzene-1,3,5-triol
sodium;(3R,5R)-7-[(1R,2S,6S,8R,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
1,1,3,3-Tetramethyl-3a-(trimethylsilyl)-8-(pentamethyldisilanyl)-1,3,3a,9b-tetrahydro-2-oxa-3-sila-2H-cyclopenta[a]naphthalene
pinen-10-yl vicianoside
A monoterpene glycoside with formula C21H34O10, originally isolated from the roots of Paeonia lactiflora.
Fumarate hydratase-IN-1
Fumarate hydratase-IN-1 (compound 2) is a cell-permeable fumarate hydratase inhibitor. Fumarate hydratase-IN-1 has antiproliferative activity against several cancer cell lines with a mean IC50 of 2.2 μM[1].